Radiance Biopharma announced it raised $250,000 in an initial filing from an offering of $30 Million
Radiance Biopharma announced it raised $250,000 in an initial filing from an offering of $30 Million
02/28/24, 8:03 PM
Location
bostonMoney raised
$250,000
Industry
biotechnology
Company Info
Location
one boston place
boston, massachusetts, united states
Additional Info
Radiance Biopharma, Inc. (“Radiance”) is a biotechnology company developing targeted cancer therapies using Antibody Drug Conjugates (ADCs). ADCs are designed to deliver greater efficacy and safety in treating cancer and other unmet clinical needs.